The Association of Provider Communication with Trust among Adults with Sickle Cell Disease

Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA.
Journal of General Internal Medicine (Impact Factor: 3.42). 03/2010; 25(6):543-8. DOI: 10.1007/s11606-009-1247-7
Source: PubMed

ABSTRACT Adults with sickle cell disease often report poor interpersonal healthcare experiences, including poor communication with providers. However, the effect of these experiences on patient trust is unknown.
To determine the association between patient ratings of the previous quality of provider communication and current trust in the medical profession among adults with sickle cell disease.
Cross-sectional survey.
A total of 95 adults with sickle cell disease.
The four-item Provider Communication Subscale from the Consumer Assessment of Healthcare Plans and Systems Survey; The five-item Wake Forest Trust in the Medical Profession Scale.
Better ratings of previous provider communication were significantly associated with higher levels of trust toward the medical profession. A 10% increase in provider communication rating was associated with a 3.76% increase in trust scores (p < 0.001, 95% CI [1.76%, 5.76%]), adjusting for patient-level demographic, clinical, and attitudinal characteristics.
Poorer patient ratings of provider communication are associated with lower trust toward the medical profession among adults with sickle cell disease. Future research should examine the impact of low trust in the medical profession on clinical outcomes in this population of patients.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A substantial number of planned clinical trials for sickle cell disease (SCD) have terminated early due to insufficient patient enrollment. To describe attitudes toward clinical trials among a sample of adults with SCD and identify patient-level factors associated with these attitudes. Our data came from a sample (N = 291) of primarily adults with SCD participating in the Improving Patient Outcomes with Respect and Trust (IMPORT) study, which is a federally funded observational study of SCD patient experiences in seeking healthcare. Attitudes toward clinical trials were assessed using items from the Perceptions of Participation in Clinical Research instrument. Patient factors examined as potential correlates of clinical trial attitudes were demographics, disease severity, engagement in self-care, trust, healthcare experience ratings, and prior history of participation in clinical trials. Multiple regression analyses were used to identify patient-level correlates of clinical trial attitudes. Our sample of SCD patients expressed overwhelmingly favorable attitudes about clinical trials, with 77%-92% of our sample expressing agreement with a series of positive statements about clinical trials in general. Demographics, engagement in self-care, healthcare experience ratings, and prior trial participation each explained significant portions of the variability in clinical trial attitudes. The generalizability of our results to the entire SCD population may be of concern as the study participants were all receiving care at comprehensive sickle cell centers and already participating in clinical research. Our results suggest that, in principle, adults with SCD enrolled in an observational study express very positive general attitudes about clinical trial participation and that specific factors attached to particular clinical trial opportunities may play a greater role in a SCD patient's decision to participate than a general unwillingness to participate.
    Clinical Trials 02/2014; 11(3). DOI:10.1177/1740774513519876 · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Poor patient-provider interaction among racial/ethnic minorities is associated with disparities in health care. In this descriptive, cross-sectional study, we examine African American women's perspectives and experiences of patient-provider interaction (communication and perceived discrimination) during their initial prenatal visit and their influences on perceptions of care received and prenatal health behaviors. Pregnant African American women (n = 204) and their providers (n = 21) completed a pre- and postvisit questionnaire at the initial prenatal visit. Women were also interviewed face to face at the subsequent return visit. Women perceived high quality patient-provider communication (PPC) and perceived low discrimination in their interaction with providers. Multiple regression analyses showed that PPC had a positive effect on trust in provider (p < .001) and on prenatal care satisfaction (p < .001) but not on adherence to selected prenatal health behaviors. Findings suggest that quality PPC improves the prenatal care experience for African American women.
    Western Journal of Nursing Research 05/2014; 37(2). DOI:10.1177/0193945914533747 · 1.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To assess disparities in the quality of healthcare provider communication experienced by African-American adults with and without sickle cell disease (SCD) in the U.S. Methods Poor provider communication was assessed by the Provider Communication subscale of the Consumer Assessment of Healthcare Plans and Systems survey. The SCD sample was obtained from participants in a multicenter observational study of healthcare experiences. The national African-American sample data was obtained from published national estimates. Results The SCD sample was more likely than the national sample to report poor communication in 3 out of 4 communication domains: Listening (22.3% vs. 11.5%, p < 0.0001); Showing Respect (26.1% vs. 9.5%, p < 0.0001); and Spending Enough Time (38.3% vs. 16.2%, p < 0.0001). Differences were consistent in young, but not old, patients and showed some variation by self-reported health status and education. Conclusions The communication difficulties experienced by persons with SCD do not appear reducible to their predominantly African-American race, but may result from more disease-specific factors. Practice Implications: Healthcare providers should take particular care in recognizing and demonstrating recommended communication skills with SCD patients as these patients may be particularly vulnerable to, and cognizant of, poor quality interactions.
    Patient Education and Counseling 08/2014; 96(2). DOI:10.1016/j.pec.2014.05.013 · 2.60 Impact Factor

Full-text (2 Sources)

Available from
May 16, 2014